Screening compound: C30H31FN4O3 (V029-3707)

Screening compound: C<sub>30</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>3</sub> (V029-3707)
Screening compound: C<sub>30</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>3</sub> (V029-3707) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C30H31FN4O3 (V029-3707)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-3707

Molecular Formula

C30H31FN4O3 (C30 H31 FN4 O3)

Compound Name

1-[(2-fluorophenyl)methyl]-5-(4-methylbenzamido)-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

IUPAC name

1-[(2-fluorophenyl)methyl]-5-(4-methylbenzamido)-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

SMILES

Cc(cc1)ccc1C(Nc(cc1)cc2c1n(Cc(cccc1)c1F)c(C(NCCN1CCOCC1)=O)c2)=O

InChI

InChI=1S/C30H31FN4O3/c1-21-6-8-22(9-7-21)29(36)33-25-10-11-27-24(18-25)19-28(35(27)20-23-4-2-3-5-26(23)31)30(37)32-12-13-34-14-16-38-17-15-34/h2-11,18-19H,12-17,20H2,1H3,(H,32,37)(H,33,36)

InChI Key

GFZNLOQMIBLEBN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19784699

C30H31FN4O3 (V029-3707) in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Kinases
  • Phosphatases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C30H31FN4O3 (V029-3707) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C30H31FN4O3 (V029-3707)?
Check Price and Availability of C30H31FN4O3 (V029-3707), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C30H31FN4O3 (V029-3707) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C30H31FN4O3 (V029-3707)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C30H31FN4O3 (V029-3707)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C30H31FN4O3 (V029-3707) available by request